The FDA said that pooled testing of donations using a screening test that it has licensed is a sufficient method for complying with its testing regulations.
A combined assay to screen blood donations for HIV and hepatitis viruses and a test for West Nile virus are now cleared to run on the Procleix Panther system.
Despite the astronomical costs, it may prove challenging to reverse course and discontinue Zika testing according to a commentary article accompanying a NEJM study.
The test is designed to detect 14 of the most prevalent mutations in the gene responsible for the disease.
The assay runs on the Procleix Panther system and detects B. microti, B. duncani, B. divergens, and B. venatorum parasites that can be transmitted by tick bites or blood donation.
Hologic's CEO said in December that the blood screening business was a drag on the company's growth.
Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.
Through their arrangement, Singulex has granted Grifols an exclusive license to its single-molecule counting technology for use in blood donor and plasma screening.
The firm's blood screening revenues received a boost from services performed for the Japanese Red Cross Society by its partner, Grifols.
The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.
The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.
Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.
In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.